Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Ding, Y. He, F. Li, Q. Zhan (Beijing, China). Value of galactomannan in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 201

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic value of galactomannan in bronchoalveolar lavage for invasive pulmonary aspergillosis in immunocompromised children Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection Year: 2009 Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Mini-bronchoalveolar lavage for diagnosing COVID-19 associated invasive pulmonary aspergillosis. Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021 Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema Source: Eur Respir J 2005; 25: 275-281 Year: 2005 Utility and cost of routine bronchoalveolar lavage in diagnosing pulmonary fungal infections Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Bronchoalveolar lavage in idiopathic pulmonary fibrosis Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Microflora analysis of bronchoalveolar lavage fluids from patients with aspiration pulmonary diseases Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 The role of bronchoalveolar lavage immunologic parameters in pulmonary sarcoidosis prognosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Bronchoalveolar lavage (BAL) as a diagnostic tool in pulmonary hypertension: occult alveolar haemorrhage is a common feature of pulmonary veno-occlusive disease (PVOD) Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003 Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Secondary pulmonary alveolar proteinosis associated with IgG4-related disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013